David Linetsky Sells 23,729 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP David Linetsky sold 23,729 shares of the stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $28.50, for a total transaction of $676,276.50. Following the completion of the transaction, the senior vice president owned 193,510 shares in the company, valued at $5,515,035. This represents a 10.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

David Linetsky also recently made the following trade(s):

• On Wednesday, June 18th, David Linetsky sold 67 shares of Phreesia stock. The stock was sold at an average price of $25.61, for a total transaction of $1,715.87.
• On Tuesday, June 17th, David Linetsky sold 42 shares of Phreesia stock. The shares were sold at an average price of $25.17, for a total transaction of $1,057.14.
• On Monday, April 21st, David Linetsky sold 260 shares of Phreesia stock. The stock was sold at an average price of $23.04, for a total value of $5,990.40.
• On Wednesday, April 16th, David Linetsky sold 4,499 shares of Phreesia stock. The stock was sold at an average price of $23.73, for a total value of $106,761.27.
• On Tuesday, April 8th, David Linetsky sold 3,944 shares of Phreesia stock. The shares were sold at an average price of $23.85, for a total value of $94,064.40.

Phreesia Stock Up 2.1%

Shares of NYSE:PHR traded up $0.60 on Wednesday, reaching $29.09. The company had a trading volume of 468,236 shares, compared to its average volume of 454,644. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $1.73 billion, a P/E ratio of -39.31 and a beta of 0.72. The stock has a 50-day moving average price of $25.75 and a 200 day moving average price of $26.16. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The business had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. Phreesia's revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the previous year, the company earned ($0.05) earnings per share. On average, equities analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Johnson Financial Group Inc. boosted its position in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after acquiring an additional 896 shares during the period. Quarry LP grew its position in Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after purchasing an additional 1,923 shares during the last quarter. KBC Group NV bought a new position in shares of Phreesia during the 1st quarter worth about $74,000. Smartleaf Asset Management LLC raised its position in shares of Phreesia by 154.6% during the fourth quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after buying an additional 2,090 shares during the last quarter. Finally, CWM LLC lifted its stake in shares of Phreesia by 994.9% in the first quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after buying an additional 3,671 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

Analysts Set New Price Targets

PHR has been the topic of several research analyst reports. DA Davidson decreased their target price on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Truist Financial increased their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. KeyCorp dropped their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Citigroup reissued a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Finally, Canaccord Genuity Group reduced their target price on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday, May 29th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $31.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.